Breaking AI & Tech News Analyzed

The Climate Policy Reversal in Blue States Democratic-led states are eroding their climate policies, as red states are scaling up their clean energy deployment. California on Friday scaled back its cap-and-invest program, offering more than $3bn in free pollution allowances to polluting companies. Earlier the same week, New York weakened its groundbreaking climate law, delaying a plan to regulate carbon from 2024 until 2028 and reducing emissions-slashing targets. Rhode Island's governor, meanwhile, is attempting to roll back aggressive clean-energy programs. The Economic Justification vs. Climate Imperative The moves come as Donald Trump's administration withdraws clean energy incentives and energy savings programs, and as energy prices spike across the country amid trade disruptions stemming from the US-Israeli war on Iran. Proponents have said the changes are necessary to suppress electricity costs, but climate advocates say that view is short-sighted and misguided. "Using affordability as a cudgel to weaken climate policy is a major error that will not solve either crisis, ultimately amplifying both," said Johanna Bozuwa, executive director of the Climate and Community Institute, a left-leaning thinktank. "Extreme weather and fossil-fuel dependency directly inflate costs – for food, energy, transportation, housing, and health – across the economy for working people." American Public Opinion on Climate Change Polls show most Americans are concerned about the climate crisis. An annual poll from Gallup, published in April, shows that 44% of American adults say they worry "a great deal" about global warming – one of the highest levels of concern since 1989, when the poll was first conducted, behind only 2020 and 2017. About 65% of registered voters in the US also think global heating is driving up the cost of living, according to a report published in December by Yale University and George Mason University. Red States Lead Clean Energy Buildout In contrast to many Democratic-led jurisdictions, red states have tended to dominate renewable energy deployment in recent years. In terms of growth of utility-scale renewables, states that voted for Donald Trump in the 2024 presidential election made up eight of the top 10 in the year to March, according to Energy Information Administration data. Indiana tops the list of states with the most clean energy capacity growth in that timeframe, followed by Kentucky and Utah. More broadly, though, it is Texas that has emerged as the country's leading clean energy superpower, despite its strong ties to the oil and gas industry and unsuccessful attempts within the Republican-led legislature to curb the growth of wind and solar. Texas leads the country in wind energy production, followed by fellow red states Iowa, Oklahoma and Kansas, and in March overtook California in utility-scale solar, too. The Paradox of Climate Leadership Meanwhile, the states scaling back their emissions-cutting policies have long called themselves climate leaders. When Governor Gavin Newsom of California extended his state's cap-and-invest program last year, he said: "We're doubling down on our best tool to combat Trump's assaults on clean air … by making polluters pay for projects that support our most impacted communities." The changes could end up giving more money to the fossil fuel producers and distributors who have been increasing consumers' energy prices amid the Iran war, said Bahram Fazeli, Policy Director with Communities for a Better Environment, a grassroots organization in California. "There's no reason to think that giving them more free allowances will actually help motivate them to lower gas prices more," he said. Long-Term Economic Implications New York advocates are also skeptical about whether the weakening of the 2019 Climate Leadership and Community Protection Act – which the state touted as among the strongest climate laws the country – will deliver long-term benefits. The state legislature last week reached a deal with Governor Kathy Hochul to remove a 2030 mandate to cut planet-warming pollution by 40% from 1990 levels, instead including language to aim for a 60% by 2040 if it is "feasible and cost effective" to do so. "Even though you might see bill savings initially, that's going to come at the cost of locked-in, higher energy costs in the future, as the grid has to procure more energy that would otherwise have been saved," Anna Johnson, a senior policy manager State at American Council for an Energy-Efficient Economy, told Baltimore's NPR affiliate WYPR; she estimates that the moves could ultimately increase households' electricity costs by $592m. The True Cost of Inaction The climate crisis itself also costs for working people, said Mar Zepeda Salazar, legislative director of the national environmental justice coalition Climate Justice Alliance. "You can lower costs on paper by weakening protections, but the bill still comes due," she said. "It just shows up in emergency rooms, insurance premiums, utility bills, lost wages, and disaster recovery – that families pay, not industry."

GLP‑1 Medications Show Promise in Reducing Breast Cancer IncidenceRecent analyses presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago suggest that patients using GLP‑1 receptor agonists—a class of weight‑loss drugs—experienced a 30% lower likelihood of being diagnosed with breast cancer compared with non‑users.Study cohort: 110,000 women aged 45‑80.Risk reduction: 30% for breast cancer onset.Lead researcher: Dr Elizabeth McDonald, University of Pennsylvania.Adjunctive Use of GLP‑1 Drugs Cuts Breast Cancer MortalityA separate investigation involving 27,000 breast‑cancer patients in Italy reported that adding a GLP‑1 agent to standard therapy was associated with a 30% decrease in cancer‑related death.Institution: IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola.Outcome: 30% lower mortality risk.Broad Cancer‑Spread Benefits Observed Across Multiple Tumor TypesData from the Cleveland Clinic, covering 12,000 patients with breast, lung, colorectal or liver cancer, indicated a 38‑50% reduction in progression to stage‑four disease among GLP‑1 users.Study size: 12,000 patients.Risk reduction range: 38%–50% for metastatic spread.Why These Findings Matter for Public Health and OncologyThe consistency of risk‑reduction signals across incidence, mortality and metastasis points to a potential paradigm shift: drugs originally designed for diabetes and obesity may become adjunct tools in cancer prevention and treatment. If confirmed, the impact could be substantial given the prevalence of obesity and the high incidence of breast cancer worldwide.Next Steps: Clinical Trials and Regulatory ConsiderationsExperts caution that the current evidence is observational. Ongoing randomized controlled trials will be needed to disentangle the effects of weight loss from direct pharmacologic actions of GLP‑1 agonists. Regulatory bodies may eventually evaluate these agents for oncologic indications, pending robust trial data.

The Lead: Biotech Barbie's Mission to Edit Human DNA Cathy Tie, a Canadian entrepreneur known as "Biotech Barbie," is pursuing a controversial mission to genetically modify embryos to prevent hereditary diseases, following in the footsteps of her ex-husband He Jiankui, who served prison time for creating the world's first gene-edited babies. Despite global bans on germline gene editing for reproductive purposes, Tie aims to conduct this work openly with regulatory approval and venture capital funding. The Technical Breakthrough: Gene Editing Made Accessible Since the invention of the Crispr-Cas9 gene editing tool in 2012, the technical process of altering DNA has become relatively straightforward. "The hardest thing about genetically engineering a baby is getting permission to do it; the technical part is not particularly complicated," the article explains. The process is compared to using "find, copy, cut and paste functions on a computer" and doesn't require extensive expertise in molecular biology. Germline gene editing—altering eggs, sperm, or early embryos—is particularly significant because changes are passed down to future generations, potentially altering human evolution permanently. This is why such procedures are banned in the UK, US, and China, with international agreement against research that could result in gene-edited babies. The Financial Landscape: Billionaires Investing in Genetic Engineering Money is flowing into human genetic engineering, with some of the world's richest men investing in companies pursuing similar goals. Preventive, a gene editing startup launched in October 2025 with the aim of "preventing disease before birth," has attracted investment from OpenAI's Sam Altman, his husband Oliver Mulherin, and Coinbase CEO Brian Armstrong. Armstrong has coined the term "the Gattaca stack"—referencing the dystopian film about a genetically engineered society—which includes technologies for "disease prevention, or enhancement" of babies. This suggests a growing interest not just in preventing diseases but in enhancing human traits. Preimplantation genetic testing (PGT), already common in the US fertility treatments, allows parents to "choose the embryo that best matches what you want," with companies like Nucleus Genomics advertising on subways with the tagline "Have your best baby." The Global Impact: A New Biological Arms Race? "There's a big geopolitical component to this," Tie states, referring to the growing interest in genetic engineering. China, where Tie was banned from entering, has already demonstrated what gene editing can do—Chinese researchers made the first edits to human embryos in 2015, and Tie's ex-husband He Jiankui created the first gene-edited babies, twin girls known as Lulu and Nana. Since his release from prison in 2022, He has become an unlikely social media star with close to 150,000 followers on X, making unrepentant posts about "designer babies" being "inevitable." Meanwhile, China's biotechnology ambitions have expanded, with Premier Li Qiang announcing new regulations emphasizing "the need to promote innovative development" and "accelerate R&D; and commercialization." In response to China's announcement, Tie posted: "Welcome to the dawn of the biological arms race." The Future Outlook: Inevitable Genetic Modification "Biology is a double-edged sword – it can be used for good, to heal people, or it can be used for bad," Tie explains. "Stopping this research will only drive bad actors to do it secretively. There is no way to stop this. This is inevitable. The only way to proceed is to do it openly and transparently." Tie named her first human gene-editing company the Manhattan Project, drawing a parallel between the nucleus of the atom and the nucleus of the cell. "In the 20th century, we understood the nucleus of the atom very well, and we learned some very difficult lessons via weapons and wars," she says. "I don't want to see the same happen with the second nucleus." Despite her declared commitment to openness, much of Tie's work remains shrouded in secrecy. Her first company, the Manhattan Project, has since shut down due to what she calls a "fundamental mistake" in choosing a co-founder. She has since launched Origin Genomics, continuing her pursuit of genetic modification of embryos.

The Lead: Apple's AI Integration MilestoneApple has approved Poke as the first standalone AI agent to operate on its Messages for Business platform, representing a significant shift in Apple's approach to third-party AI integration. This approval comes just days before Apple's Worldwide Developers Conference (WWDC), where the tech giant is expected to unveil AI-optimized Siri and other AI tools.The Breakthrough: Opening Messages for Business to AI AgentsPreviously, Apple's Messages for Business platform was exclusively designed for businesses—such as airlines, retailers, and hotel chains—to communicate with their customers through Apple's Messages app. The platform offered a standardized interface supporting both automated chat and live agents but had never been open to standalone third-party AI agents until now.Poke, launched in March, is designed to be accessible to everyday users without technical expertise. It helps with common activities like daily planning, calendar management, health tracking, smart home control, and photo editing—all via text message. To date, it has processed 100 million messages across SMS, Telegram, and WhatsApp. With this approval, Poke will add Apple Messages for Business to its supported platforms.The Financial Impact: Business Model and ValuationThe approval opens up a new business model for Poke and potentially other AI agents. According to co-founder Marvin von Hagen, Poke pays its messaging service provider on a per-user basis, with pricing significantly lower than Meta AI after its fee increases. The 10-person startup, backed by Spark Capital and General Catalyst, recently secured an additional $10 million, following last year's $15 million seed round, and is now valued at $300 million post-money.Getting Apple's approval required demonstrating the ability to offer live support when needed, clearly identifying the AI agent, and customizing the user interface to meet Apple's guidelines. This process took Poke several months, with von Hagen noting that other companies looking to build on this platform should expect a similar timeline.Industry Transformation: Apple's AI Strategy ShiftThis approval signals a potential shift in Apple's AI strategy. While Apple hasn't opened its App Store to AI agents as rumored, the approval of Poke on Messages for Business suggests the company is exploring ways to integrate third-party AI into its ecosystem. The move positions Apple to compete with other tech giants that have embraced AI agents more aggressively.For consumers, this means more AI-powered services accessible through familiar interfaces like the Messages app. For businesses, it could open new avenues for customer interaction through AI agents. The approval also highlights Apple's focus on quality and trust, as von Hagen emphasized that Poke's brand positioning aligned with Apple's standards.Future Outlook: Expanding AI IntegrationLooking ahead, Poke is rolling out invites to existing users to optionally move to the Apple Messages for Business platform, with plans to continue offering subscriptions that include Apple Pay options. While it's unclear if Apple will announce additional AI agent initiatives at WWDC, von Hagen believes Apple's support for AI agents will grow over time.This approval could pave the way for more AI agents on Apple's platforms, potentially transforming how users interact with both businesses and AI services. As Apple continues to develop its AI strategy, the integration of third-party AI agents like Poke could become a key differentiator in the competitive AI landscape.

Liverpool's Swift Managerial ChangeRichard Hughes and Michael Edwards have acted with decisiveness and a clear sense of what Liverpool's difficult situation demanded in switching head coaches within six days, although the appointment of Andoni Iraola removes just one layer of uncertainty from Anfield. Several others remain, including their roles in leading Liverpool's recovery alongside Arne Slot's successor.With supporters turning against Slot's football and more players liking Mohamed Salah's critical social media post than wishing the Dutchman well following his sacking, Liverpool could not allow disillusionment to fester and needed to move fast. Sporting director Hughes and Edwards, chief executive of football for the club's owner Fenway Sports Group, have delivered.Iraola's Appointment: Style and PhilosophyIn Iraola, who was coveted by Milan, Bayer Leverkusen and Crystal Palace after improving Bournemouth in each of his three seasons on the south coast, those in charge of football operations at Liverpool have hired a coach who promises a version of the aggressive attacking style that captivated the Kop under Jürgen Klopp. But winning is what captivates Anfield most of all and there is much more to the appointment of Iraola than style of play.Liverpool's new head coach has demonstrated a flair for improving individual players and handling disruption with minimal fuss. Slot may have lost his way on all counts, but still delivered Champions League qualification in the most trying circumstances and under a most unforgiving spotlight.Liverpool's Investment and Performance DeclineThe urgency behind the move for Iraola was not only a reaction to external pressures and the despondency that had set in at Anfield over the final weeks of last season. Several attractive clubs are in the market for a new manager before the World Cup and there is a limited pool of talent available.With the Basque holding talks with Leverkusen and Milan, and Liverpool's powerbrokers convinced of his suitability and ability, FSG needed to sign off on their recommendations quickly. The World Cup will disrupt Iraola's first pre-season and there is much to be done to turn the trajectory of a team in decline.New signings are the obvious place to start. Slot believed the addition of two wingers this summer would catapult Liverpool back to the levels of his title-winning campaign, finally filling the voids left by Luis Díaz's departure and Salah's dramatic drop in form. Liverpool agree with their former head coach on that score and two wingers remain their priority.The Challenge of Managing at AnfieldBournemouth operate in a completely different environment. Iraola surviving at the Vitality Stadium after a nine-game winless start to his Premier League career is testament to that. "We didn't start well and, probably, you were thinking: 'Who the fuck is this guy?'" Iraola joked at his Bournemouth farewell.Anfield would not be pondering that question during a nine-game winless run but screaming it at those responsible. Unwavering support for a Liverpool manager is not guaranteed, as Slot discovered 13 months after delivering the title in his debut season and having faced unprecedented challenges in his second.But Iraola has been hired because Liverpool also firmly believe he can get the best out of players already in the building. The judgment of Hughes and Edwards is likely to stand or fall by this conviction. Liverpool's reputation for astute trading and forward thinking, well established in the Klopp/Edwards era, has taken a battering after last summer's record investment of almost £450m yielded dismal results.Iraola's Path to Liverpool's RecoveryLiverpool remain convinced they acquired talent that can deliver the biggest prizes. The eyes on last season say differently, although there is substance to the argument that Slot struggled to find the best position for Florian Wirtz or play to the strengths of Alexander Isak. Liverpool's former head coach could respond with an injury list that restricted Isak, Wirtz and Hugo Ekitiké to less than two hours together on the same pitch last season.Isak appeared ill-suited to Liverpool on the few occasions he was match fit but a more dynamic approach under Iraola, who wants the ball released into his forwards as early as possible, should make the Sweden international more effective. Wirtz, clearly gifted but too often on the periphery in his debut Liverpool campaign, should also benefit from the shift in style plus the addition of two fast wingers.Iraola's work with defenders is another part of his appeal to Liverpool. At Bournemouth he coached Illia Zabarnyi, Dean Huijsen and Milos Kerkez into talents worthy of big money moves to Paris Saint-Germain, Real Madrid and Liverpool respectively. Not one has had the same impact since leaving the Vitality Stadium.

Bolton’s Guilty Plea: One Count of Illegal Document RetentionJohn Bolton, once Trump’s national security adviser and now a vocal critic, has agreed to plead guilty to one count of illegally retaining sensitive national‑security documents. The plea follows his October indictment by the Department of Justice, which originally charged him under the Espionage Act with 18 counts.Financial Penalty: More Than $2 Million FineThe agreement includes a monetary sanction of over $2 million. This fine reflects the government’s assessment of the seriousness of the breach, which involved the transmission of roughly 1,000 pages of “diary‑like entries”—some marked “top secret”—to two relatives.Political Fallout: A New Chapter in Trump’s Retaliation CampaignBolton’s deal arrives amid a broader pattern of prosecutions targeting Trump allies and critics, including former FBI Director James Comey and New York Attorney General Letitia James. Observers note that the timing underscores President Donald Trump’s willingness to leverage federal charges as a tool against perceived opponents, a strategy that has drawn criticism for threatening prosecutorial independence.Future Outlook: Legal Precedents and Potential Ripple EffectsLegal experts caution that Bolton’s case could set a precedent for how the Espionage Act is applied to former officials who become political adversaries. While the plea avoids a protracted trial, it may embolden further investigations into other former Trump officials and shape the DOJ’s approach to classified‑information violations in the coming years.

Meta's New AI Creator Assistant Meta announced on Thursday that it’s introducing a new AI creator assistant on Facebook that will give creators personalized recommendations based on their content style, performance, community, and goals. Simplifying Creator Analytics Creators often have to parse through charts and dashboards to understand their performance, but with the new AI assistant, they can get quick answers to questions like “When should I post?” and “What are people saying in my comments?” Conversational Insights Since the AI assistant is conversational, they can ask follow-up questions and dig deeper on a topic, like how their audience has shifted over time. The answers they receive will be based on their own presence and what they can do differently to improve performance. Brainstorming Content Ideas Beyond performance, the AI assistant can help brainstorm ideas for new content by drawing on what’s trending. For example, it may suggest using trending audio or creating content around cultural moments. Rollout and Future Plans The new assistant is rolling out to creators in the U.S., Canada, and India. Meta plans to add new capabilities and bring the assistant to more countries in the future. Competition and Strategy By giving creators access to an AI assistant, Meta is looking to keep creators active on Facebook as it competes for their attention against rivals like TikTok and YouTube. Additionally, by offering creators content ideas, Facebook is encouraging more frequent posting, which could in turn boost user engagement. Additional Features In-app access to an AI assistant also gets rid of the need for creators to turn to third-party tools like ChatGPT when brainstorming and understanding performance, keeping them within Meta’s ecosystem. Meta also announced that it’s introducing new languages for AI translations on Facebook, including Arabic, Bahasa Indonesian, French, Thai, and Vietnamese. With AI-translated Reels, a creator’s tone and sound are preserved and automatically translated into another language. Adoption and Impact Meta says over half a billion users on Facebook are now watching AI-translated videos weekly.

The Lead: A Live Tracker of the Golden Boot RaceThe Guardian’s new interactive visualises the top goal‑scorers in the 2026 World Cup, updating in real time as matches conclude. It offers a quick reference for fans and analysts to see who is in contention for the coveted Golden Boot. The Golden Boot Competition OverviewThe Golden Boot is awarded to the player who scores the most goals throughout the tournament. The interactive groups players by total goals, matches played, and goal‑per‑game ratio, allowing users to compare efficiency as well as raw totals. Scoring Leaders SnapshotCurrent leaders are displayed with their goal tallies beside their national flags.Players are ranked by total goals, with tie‑breakers based on assists and minutes played.The tool highlights emerging contenders from both traditional powerhouses and surprise nations. Implications for Players and TeamsLeading the scoring charts can boost a player’s market value, attract endorsement deals, and increase tactical focus from opponents. Teams with a Golden Boot contender often see heightened media attention and strategic adjustments aimed at protecting or exploiting that player’s form. The Outlook for the Rest of the TournamentAs the group stage concludes and the knockout rounds begin, the interactive will continue to update, reflecting the impact of tighter defenses and higher stakes. Analysts will watch for shifts in momentum that could propel a dark‑horse scorer into the lead.

Emergency Funding Fuels Three Vaccine CandidatesThe Coalition for Epidemic Preparedness Innovations (CEPI) announced $60 million in emergency grants to fast‑track three vaccine programmes targeting the Bundibugyo strain of Ebola. The funding is split among IAVI, Oxford University (in partnership with the Serum Institute of India), and Moderna, each racing to move from pre‑clinical work to human trials.Projected Timelines for Vaccine TrialsIAVI vaccine: WHO labels it the “most promising candidate”. Expected to enter clinical trials in seven to nine months, though IAVI aims to accelerate.Oxford vaccine (ChAdOx1 Bundibugyo): Leveraging the same platform as the Oxford/AstraZeneca COVID‑19 jab, trials could start within two to three months pending animal data.Moderna vaccine: mRNA‑based candidate not yet on WHO’s list; pre‑clinical work could allow trial initiation within months after CEPI’s additional $50 million commitment.Financial Commitments and Their SignificanceThe combined $110 million from CEPI ($60 million emergency grant + $50 million for Moderna) underscores the urgency of a coordinated response. These funds cover pre‑clinical development, manufacturing scale‑up, and the logistical costs of conducting trials in a conflict‑affected region.Operational Challenges in the DRC and UgandaSecurity instability in eastern DRC—where militias have attacked Ebola treatment centres—has hampered trial set‑up and patient recruitment. Researchers, including Dr Richard Hatchett (CEPI CEO), stress that “every day counts” but note that safe trial execution depends on stabilising the environment and securing community trust.Potential Therapeutic Options Beyond VaccinesMonoclonal antibodies MBP134 and Maftivimab show promise in early studies.The antiviral remdesivir is being evaluated for efficacy against Bundibugyo.A novel prevention pill, obdeldesivir, demonstrated up to 100 % protection in monkey models when administered daily for ten days.Outlook: When Might Effective Countermeasures Arrive?If security conditions improve, the Oxford candidate could enter Phase 1 trials by late summer 2026, while IAVI’s schedule may see first‑in‑human dosing by early 2027. Moderna’s mRNA platform could follow a similar timeline, contingent on pre‑clinical results. Successful trials could lead to emergency use authorisations within a year of dosing, offering the first targeted tools against the Bundibugyo strain and informing preparedness for future Ebola outbreaks.